{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:26:32Z","timestamp":1779377192654,"version":"3.53.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[1995,6,1]],"date-time":"1995-06-01T00:00:00Z","timestamp":801964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1995,6,1]],"date-time":"1995-06-01T00:00:00Z","timestamp":801964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm Gen Sect"],"published-print":{"date-parts":[[1995,6]]},"DOI":"10.1007\/bf02259660","type":"journal-article","created":{"date-parts":[[2005,11,23]],"date-time":"2005-11-23T09:32:53Z","timestamp":1132738373000},"page":"189-196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["CSF somatostatin increase in patients with early parkinsonian syndrome"],"prefix":"10.1007","volume":"9","author":[{"given":"A.","family":"Espino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Calopa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ortol\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Peres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[1995,6,1]]},"reference":[{"key":"BF02259660_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0003-2697(85)90620-7","volume":"148","author":"G Achilli","year":"1985","unstructured":"Achilli G Perego C, Ponzio F (1985) Application of the dual-cell coulometric detector: a method for assaying monoamines and their metabolites. Anal Biochem 148: 1\u20139","journal-title":"Anal Biochem"},{"issue":"S1","key":"BF02259660_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/mds.870040514","volume":"4","author":"Y Agid","year":"1989","unstructured":"Agid Y, Cervera P, Hirsch E, Javoy-Agid F, Lehericy S, Raisman R, Ruberg M (1989) Biochemistry of Parkinson's disease 28 years later: a critical review. Mov Disord 4:S1: 126\u2013144","journal-title":"Mov Disord"},{"key":"BF02259660_CR3","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3181\/00379727-148-38631","volume":"148","author":"A Arimura","year":"1975","unstructured":"Arimura A, Sato H, Coy DH, Schally AV (1975) Radioimmunoassay of GH-release inhibiting hormone. Proc Soc Exp Biol Med 148: 784","journal-title":"Proc Soc Exp Biol Med"},{"key":"BF02259660_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0304-3940(84)90034-X","volume":"44","author":"MF Beal","year":"1984","unstructured":"Beal MF, Martin JB (1984). The effect of somatostatin on striatal catecholamines. Neurosci Lett 44: 271\u2013276","journal-title":"Neurosci Lett"},{"key":"BF02259660_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0022-510X(85)90039-5","volume":"71","author":"MF Beal","year":"1985","unstructured":"Beal MF, Mazurek MF, Black P, Martin JB (1985) Human cerebrospinal fluid somatostatin in neurologic disease. J Neurol Sci 71: 91\u2013104","journal-title":"J Neurol Sci"},{"key":"BF02259660_CR6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1212\/WNL.36.2.294","volume":"36","author":"MF Beal","year":"1986","unstructured":"Beal MF, Growdon JH, Mazurek MF, Martin JB (1986a) CSF somatostatin-like immunoreactivity in dementia. Neurology 36: 294\u2013297","journal-title":"Neurology"},{"key":"BF02259660_CR7","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/0006-8993(86)90644-X","volume":"397","author":"MF Beal","year":"1986","unstructured":"Beal MF, Mazurek MF, Martin JB (1986b) Somatostatin immunoreactivity is reduced in Parkinson's disease dementia with Alzheimer's changes. Brain Res 397: 386\u2013388","journal-title":"Brain Res"},{"key":"BF02259660_CR8","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4: 561\u2013571","journal-title":"Arch Gen Psychiatry"},{"key":"BF02259660_CR9","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/0024-3205(92)90534-V","volume":"51","author":"G Bisette","year":"1992","unstructured":"Bisette G, Myers B (1992) Minireview: somatostatin in Alzheimer's disease and depression. Life Sci 51: 1389\u20131410","journal-title":"Life Sci"},{"key":"BF02259660_CR10","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1002\/ana.410320721","volume":"32","author":"DB Calne","year":"1992","unstructured":"Calne DB, Snow BJ, Lee C (1992) Criteria for diagnosing Parkinson's disease. Ann Neurol 32: S125-S127","journal-title":"Ann Neurol"},{"key":"BF02259660_CR11","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1523\/JNEUROSCI.03-01-00232.1983","volume":"3","author":"MF Chesselet","year":"1983","unstructured":"Chesselet MF, Reisine TD (1983) Somatostatin regulates dopamine release in rat striatal slices and cat caudate nuclei. J Neurosci 3: 232\u2013236","journal-title":"J Neurosci"},{"key":"BF02259660_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0022-510X(93)90316-Q","volume":"116","author":"L-G Chia","year":"1993","unstructured":"Chia L-G Cheng F-C, Kuo J-S (1993) Monoamines and their metabolites in plasma and lumbar cerebrospinal fluid of Chinese patients with Parkinson's disease. J Neurol Sci 116: 125\u2013134","journal-title":"J Neurol Sci"},{"key":"BF02259660_CR13","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/BF00230196","volume":"94","author":"F Crespi","year":"1993","unstructured":"Crespi F (1993) Functional in vivo interaction between growth hormone and dopamine systems are correlated to changes in striatal somatostatin levels as detected by voltammetry. Exp Brain Res 94: 363\u2013370","journal-title":"Exp Brain Res"},{"key":"BF02259660_CR14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1212\/WNL.32.3.312","volume":"32","author":"E Dupont","year":"1982","unstructured":"Dupont E, Christensen SE, Hansen AP, et al (1982) Low cerebral fluid somatostatin in Parkinson disease: an irreversible abnormality. Neurology 32: 312\u2013314","journal-title":"Neurology"},{"key":"BF02259660_CR15","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/0006-8993(83)90277-9","volume":"278","author":"J Epelbaum","year":"1983","unstructured":"Epelbaum J, Ruberg M, Moyse E., Jovoy-Agid F, Dubois B, Agid Y (1983) Somatostatin and dementia in Parkinson's disease. Brain Res 278: 376\u2013379","journal-title":"Brain Res"},{"key":"BF02259660_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/BF02253436","volume":"7","author":"A Espino","year":"1994","unstructured":"Espino A, Ambrosio S, Bartrons R, Bendahan G, Calopa M (1994) Cerebrospinal monoamine metabolites and amino acid content in patients with parkinsonian syndrome and rats lesioned with MPP+. J Neural Transm [P-D Sect] 7: 167\u2013176","journal-title":"J Neural Transm [P-D Sect]"},{"key":"BF02259660_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/brain\/104.1.167","volume":"104","author":"EV Evarts","year":"1981","unstructured":"Evarts EV, Ter\u00e4r\u00e4inen H, Calne DB (1981) Reaction time in Parkinson's disease. Brain 104: 167\u2013186","journal-title":"Brain"},{"key":"BF02259660_CR18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.2042-7158.1978.tb13342.x","volume":"30","author":"JA Garc\u00eda Sevilla","year":"1978","unstructured":"Garc\u00eda Sevilla JA, Athee L, Magnusson T, Carlsson A (1978) Opiate receptor mediated changes in monoamine synthesis in rat brain. Pharm Pharmacol 30: 613\u2013621","journal-title":"Pharm Pharmacol"},{"key":"BF02259660_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/BF01249114","volume":"84","author":"P Hartikainen","year":"1991","unstructured":"Hartikainen P, Soininen H, Reinikainen KJ, Sirvi\u00f6 J, Soikkeli R, Riekkinen PJ (1991) Neurotransmitter markers in the cerebrospinal fluid of normal subjects. Effects of aging and other confounding factors. J Neural Transm [GenSect] 84: 103\u2013117","journal-title":"J Neural Transm [GenSect]"},{"key":"BF02259660_CR20","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD (1967) Parkinsonism: onset progression and mortality. Neurology 17: 427\u2013442","journal-title":"Neurology"},{"key":"BF02259660_CR21","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/jnnp.52.11.1221","volume":"52","author":"SJ Huber","year":"1989","unstructured":"Huber SJ, Shutteleworth EC, Christy JA, Chakeres DW, Curtin A, Paulson GW (1989) Magnetic resonance imaging in dementia of Parkinson's disease. J Neurol Neurosurg Psychiatry 52: 1221\u20131227","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02259660_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hugues","year":"1992","unstructured":"Hugues AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02259660_CR23","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1136\/jnnp.49.12.1374","volume":"49","author":"J Jolkkonen","year":"1986","unstructured":"Jolkkonen J, Soininen H, Halonen T, Ylinen A, Laulumaa V, Laakso M, Riekkinen P (1986) Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia. J Neurol Neurosurg Psychiatry 49: 1374\u20131377","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02259660_CR24","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0143-4179(90)90016-R","volume":"15","author":"S Jost","year":"1990","unstructured":"Jost S, Reuner C, Mohadjer M, Mundinger F, Cramer H (1990) Ventricular fluid neuropeptides in Parkinson's disease. Neuropeptides 15: 219\u2013225","journal-title":"Neuropeptides"},{"key":"BF02259660_CR25","first-page":"285","volume-title":"Quantification of neurologic deficit","author":"AE Lang","year":"1989","unstructured":"Lang AE, Fann S (1989) Assesment of Parkinson's disease. In: Munsat TL (ed) Quantification of neurologic deficit. Butterworths, Boston, pp 285\u2013309"},{"key":"BF02259660_CR26","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1212\/WNL.42.11.2111","volume":"42","author":"PA LeWitt","year":"1992","unstructured":"LeWitt PA, Galloway MP, Matson W, Milbury P, McDermott M, Srivastava DK, Oakes D, Parkinson Study Group (1992) Markers of dopamine metabolism in Parkinson's disease. Neurology 42: 2111\u20132117","journal-title":"Neurology"},{"key":"BF02259660_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1532-5415.1990.tb01591.x","volume":"38","author":"H Masson","year":"1990","unstructured":"Masson H, Popescu I, Strubel D, Cramer H, Kuntzmann F (1990) Somatostatin-like immunoreactivity in the cerebrospinal fluid of aged patients with Parkinson's disease. The effect of dopatherapy. J Am Geriatr Soc 38: 19\u201324","journal-title":"J Am Geriatr Soc"},{"key":"BF02259660_CR28","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1136\/jnnp.53.12.1105-a","volume":"53","author":"W Poewe","year":"1990","unstructured":"Poewe W, Benke T, Karamat E, Schelosky L, Wagner M (1990) CSF somatostatin-like immunoreactivity in dementia of Parkinson's disease. J Neurol Neurosurg Psychiatry 53: 1105\u20131106","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02259660_CR29","volume-title":"L'examen clinique en psychologie","author":"A Rey","year":"1964","unstructured":"Rey A (1964) L'examen clinique en psychologie. Presses Universitaires de France, Paris"},{"key":"BF02259660_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0022-510X(79)90050-9","volume":"42","author":"E Schneider","year":"1979","unstructured":"Schneider E, Fischer P, Jacobi P, Becker H, Harker H (1979) The significance of cerebral atrophy for the symptomatology of Parkinson's disease. J Neurol Sci 42: 187\u2013197","journal-title":"J Neurol Sci"},{"key":"BF02259660_CR31","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/00001756-199205000-00009","volume":"3","author":"MM Strittmatter","year":"1992","unstructured":"Strittmatter MM, Cramer H (1992) Parkinson's disease and dementia: clinical and neurochemical correlations. Neuroreport 3 413\u2013416","journal-title":"Neuroreport"},{"key":"BF02259660_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/BF02260911","volume":"5","author":"H Tohgi","year":"1993","unstructured":"Tohgi H, Abe T, Takahashi S, Nozaki Y, Ueno M, Kikuchi T (1993) Monoamine metabolism in the cerebrospinal fluid in Parkinson's disease: relationship to clinical symptoms and subsequent therapeutic outcomes. J Neural Transm [P-D Sect] 5: 17\u201326","journal-title":"J Neural Transm [P-D Sect]"},{"key":"BF02259660_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1212\/WNL.36.1.89","volume":"36","author":"L Volicer","year":"1986","unstructured":"Volicer L, Beal MF, Direnfeld LK, Marquis JK, Albert ML (1986) CSF cyclic nucleotides and somatostatin in Parkinson's disease. Neurology 36: 89\u201392","journal-title":"Neurology"}],"container-title":["Journal of Neural Transmission - Parkinson's Disease and Dementia Section"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02259660.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02259660\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02259660","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02259660.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T04:03:46Z","timestamp":1750824226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02259660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,6]]},"references-count":33,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[1995,6]]}},"alternative-id":["BF02259660"],"URL":"https:\/\/doi.org\/10.1007\/bf02259660","relation":{},"ISSN":["0936-3076"],"issn-type":[{"value":"0936-3076","type":"print"}],"subject":[],"published":{"date-parts":[[1995,6]]},"assertion":[{"value":"11 July 1994","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 1994","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 1995","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}